Envista Holdings (NVST), the dental platform spun off from Danaher, is positioned as a compelling value opportunity, earning a Zacks #2 (Buy) Rank and strong 'B' ratings for both its Value and VGM Style Scores. This assessment is supported by an attractive forward P/E of 19.25, upward revisions to its fiscal 2025 earnings estimates by seven analysts, increasing the Zacks Consensus to $1.12 per share, and a historical average earnings surprise of +16.5%, suggesting potential outperformance for investors.
Envista Holdings (NVST) is presented as a compelling value investment, underpinned by positive analyst sentiment and quantitative metrics from the Zacks rating system. The company has secured a Zacks #2 (Buy) Rank, complemented by a 'B' grade for both its Value and overall VGM Style Scores. This valuation-focused thesis is supported by a forward P/E ratio of 19.25. More significantly, the consensus earnings estimate for fiscal 2025 has seen positive revisions, increasing by $0.09 to $1.12 per share following upward revisions from seven analysts within the past 60 days. This trend in analyst sentiment is reinforced by a historical performance track record, where NVST has posted an average positive earnings surprise of 16.5%, suggesting a pattern of exceeding market expectations. As the former dental platform of Danaher, the company's foundation is built upon the integration of over 25 dental businesses, providing it with an established market presence.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment